drugset / Trial / NCT07116616
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of mRNA-2808 in participants with relapsed or refractory multiple myeloma (RRMM).
Timeline
- Start
- 2025-09-30
- Primary completion
- 2030-06-17
- Completion
- 2032-06-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mRNA-2808 | Unknown | — | Intravenous |